Bethesda, MD Clinical Trials Report — June 2026

For Bethesda residents considering participation in clinical research, June 2026 presents a mix of urgent opportunities and new avenues for contributing to medical science. Across Bethesda, MD, a total of 840 clinical trials are currently recruiting across 125 research facilities.

A significant number of trials are nearing their enrollment deadlines, making prompt action essential for interested individuals. There are currently 42 trials slated to conclude within the next 90 days. This urgency is particularly relevant for healthy volunteers, as 17 of these rapidly closing studies are still actively seeking participants without specific health conditions. These trials offer a chance to contribute to medical advancements before their enrollment windows close.

Impending Deadlines for Key Health Areas

Patients managing specific health conditions also face impending deadlines to join research. Trials focused on various conditions are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Cardiovascular disease (3 trials)
• Normal physiology (2 trials)
• Metastatic malignant solid neoplasm (2 trials)
• Unresectable malignant solid neoplasm (2 trials)
• Stroke (2 trials)
• HIV (2 trials)
• Anaplastic oligodendroglioma (1 trial)
• Anaplastic meningioma (1 trial)
• Alcohol use disorder (1 trial)
• Autism spectrum disorder (1 trial)

New Research Opportunities Emerge

This month, Bethesda saw the opening of 9 new clinical trials, a slight decrease from the 11 trials that launched in May 2026. These new studies bring fresh opportunities for participation across various health areas.

June brings several notable new trials to Bethesda, including studies from prominent sponsors like the National Institutes of Health and the Henry M. Jackson Foundation. These trials offer participants the chance to engage with cutting-edge research and diagnostic approaches across a range of health challenges.

• The National Institutes of Health Clinical Center (CC) is sponsoring NCT07647549, "Pulmonary Hypertension (PH) Biorepository for Translational Research." This study aims to create a repository of blood samples and health information from 1,000 people with pulmonary hypertension, a condition involving high blood pressure in the lung's blood vessels. Researchers hope to use this information to better understand and treat PH.
• The National Institute of Mental Health (NIMH) is initiating NCT07640802, "Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy." This study seeks 300 participants to compare different types of therapy for irritability in children, a common reason for seeking mental health care.
• The Henry M. Jackson Foundation for the Advancement of Military Medicine is sponsoring NCT07652580, "Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma." This observational cohort study aims for 300 participants to investigate the relationship between toxin/occupational exposures, genetic variation, and immune dysregulation in B-cell non-Hodgkin lymphoma among military service members and beneficiaries.

New trials this month are exploring a range of conditions, with single trials opening for adenoid cystic carcinoma, attention deficit hyperactivity disorder, b-cell lymphoma, breast cancer, breast carcinoma, cancer of the breast, carcinoma of larynx, Crohn's disease, disruptive mood dysregulation disorder, and head and neck cancer. Drug trials account for the largest share of new studies, with 4 new drug trials, followed by 1 behavioral study, 1 biological study, and 1 other type of study.

The National Cancer Institute (NCI) sponsored 3 of the new trials, while the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Mental Health (NIMH) each sponsored 2. The National Institutes of Health (NIH) as a whole sponsored 8 of the new trials, highlighting the strong academic research presence in Bethesda.

Opportunities for Healthy Volunteers

For individuals without a specific medical condition, there are significant opportunities to contribute to research. Of the 9 new trials launched this month, 1 is actively seeking healthy volunteers. Across Bethesda, a total of 282 clinical trials are currently recruiting healthy participants, providing numerous avenues for those interested in supporting medical research.

Bethesda's Leading Research Facilities

Bethesda is home to some of the nation's leading research institutions, which consistently run a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:

• National Institutes of Health Clinical Center (598 trials)
• Walter Reed National Military Medical Center (67 trials)
• Research Site (14 trials)
• National Cancer Institute Developmental Therapeutics Clinic (12 trials)
• Suburban Hospital (9 trials)
• National Institutes of Health (7 trials)
• Mid-Atlantic Epilepsy and Sleep Center (7 trials)
• National Cancer Institute (6 trials)
• The Center for Cancer and Blood Disorders (6 trials)
• National Institute of Health (5 trials)
• American Oncology Partners of Maryland, PA (5 trials)
• Uniformed Services University of the Health Sciences (4 trials)

These institutions offer a broad spectrum of research, from extensive studies at the National Institutes of Health Clinical Center to specialized care at Walter Reed National Military Medical Center and the National Cancer Institute.

Broadening Your Search: Nearby Options

While Bethesda offers a vast array of clinical trial opportunities, individuals may also find options in nearby communities within Maryland. Cities with active trials include Baltimore (20 trials), Rockville (6 trials), Silver Spring (3 trials), Potomac (2 trials), Lutherville-Timonium (2 trials), Pikesville (2 trials), Brooklyn (1 trial), and Columbia (1 trial).

Participation in clinical trials is open to a diverse range of individuals. Of the 9 new trials launched this month, 8 include older adults, ensuring that senior populations have ample opportunity to contribute to medical science. Additionally, 2 new trials include children. There are no new female-only or male-only trials this month.

As we move through June, Bethesda's robust research community will continue to drive medical innovation, offering diverse opportunities for individuals to contribute to the future of healthcare and advance medical knowledge.